{
    "nctId": "NCT01276938",
    "briefTitle": "Exclusive Intraoperative Radiation Therapy for Breast Cancer",
    "officialTitle": "Tolerance Evaluation of Exclusive Intraoperative Radiation Therapy at Different Doses for Breast Cancer Conservative Treatment",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms, Toxicity",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2, PHASE3",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Early toxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Non lobular epithelial breast carcinoma, excised with standard quadrantectomy\n* Age \u2265 45 and \\< 85\n* Tumor major diameter \u2264 2.5 cm\n* Negative surgical margins (\u2265 5 mm)\n* Willingness to undergo follow up examinations\n* Willingness to undergo imaging examinations (MRI, mammograms, ultrasonography)\n* Signed informed consent\n\nExclusion Criteria:\n\n* Ductal carcinoma in situ or lobular carcinoma\n* Extensive intraductal component (greater than 25%) or intraductal carcinoma with microinvasion\n* Serious concomitant disease or any disorder or condition (such as psychiatric or addictive disorders) that, in the opinion of the investigator, would preclude the patient from meeting the study requirements\n* Pregnancy or lactation at the time of enrolment proposal (if necessary, during the trial patients must use effective contraceptive device)\n* Collagen vascular disorders",
    "sex": "FEMALE",
    "minimumAge": "45 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}